The integration of AJCC staging with CKAP4/PLOD2 spatial expression patterns achieved superior prognostic accuracy compared to serum biomarkers, with the combined model demonstrating greater predictive power than individual factors in assessing HCC prognosis. This evidence concerns the gene PLOD2 and hepatocellular carcinoma.